The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.

[1] Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas.

In 2013, the company launched its sequencing platform[3] and was listed on the Nasdaq Stock Market as NEO.

In 2014, NeoGenomics launched molecular tests including BTK and CALR mutation analysis.

[6][7] Clarient is headquartered in Aliso Viejo, California; with an ancillary laboratory in Houston, Texas.